Get 20% lifetime commission for referring investors to digrin.com
here.
Hepion Pharmaceuticals, Inc. (HEPA) Financials
HEPA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.9 million | 648923 |
| March 31, 2026 | 2.7 million | 848747 |
| Dec. 31, 2025 | 3.1 million | 402405 |
| Sept. 30, 2025 | 3.7 million | 415808 |
HEPA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.4 million | ? |
| March 31, 2026 | 578580 | ? |
| Dec. 31, 2025 | -332775 | ? |
| Sept. 30, 2025 | -445963 | ? |
HEPA Net Income
No data available :(
HEPA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.6 million | - | - |
| March 31, 2026 | 2.6 million | - | - |
| Dec. 31, 2025 | 1.8 million | - | - |
| Sept. 30, 2025 | 2.3 million | - | - |
HEPA Shares Outstanding
HEPA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 4 | 50918 | 1.2 million | - |
| March 31, 2026 | 4 | 70000 | 728509 | - |
| Dec. 31, 2025 | - | - | 609683 | - |
| Sept. 30, 2025 | - | - | 527902 | - |
HEPA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
HEPA
Price: $0.10
52 week price:
Earnings Per Share: -0.31 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 70741
Market Capitalization: 12.1 million